Incorporated in 1911, International Business Machines, or IBM, is one of the oldest technology companies in the world... Show more
IBM, formally International Business Machines Corporation, has spent several years repositioning from a hardware-and-services legacy into a software-led, hybrid-cloud and AI platform company. Software now accounts for about 45% of revenue and an even larger share of profit, supported by four pillars: hybrid cloud (Red Hat), automation, data, and transaction processing. Red Hat revenue grew 11% in the most recent quarter, while Data revenue rose 18% on a constant-currency basis, underscoring the shift toward recurring, higher-margin streams.
The company's competitive advantage rests on its ability to serve large, regulated enterprises that need to manage workloads across public and private clouds. OpenShift, IBM's Kubernetes-based hybrid-cloud platform, has reached roughly $2.2 billion in ARR, while acquisitions such as HashiCorp (infrastructure automation), Apptio (technology cost management), and Confluent (data streaming) deepen its reach into the data and AI stack. At the same time, IBM faces structural competition from Microsoft, Oracle, and hyperscaler platforms, and its transaction-processing and mainframe businesses remain cyclical.
Several developments could shape IBM's stock forecast in the coming quarters. First, second-half software conversion is pivotal: management indicated that roughly a third of the large capex-linked deals that slipped in the second quarter had already closed early in the third, and a strong pipeline could push software growth toward the high end of the 6%–8% full-year range.
Second, earnings releases remain key checkpoints for whether the company can hit its 2026 guidance of 4%–5% constant-currency revenue growth, roughly $1 billion of incremental free cash flow, and 100 basis points of operating pre-tax margin expansion. Third, the z17 mainframe cycle — running at roughly 130% of the prior program — provides a recurring software multiplier, even as IBM Z hardware revenue normalizes after a sharp second-quarter decline.
Fourth, capital allocation and policy catalysts matter: IBM secured a $1 billion award from the U.S. Department of Commerce under the CHIPS and Science Act, supporting its semiconductor and quantum ambitions. Finally, analyst ratings and price targets have become more mixed. JPMorgan upgraded the stock to Overweight in mid-2026, and Bank of America raised its target to $330 before later trimming it to $280; Morgan Stanley and BMO carry Hold ratings near $230–$293, while HSBC moved to a more cautious stance. Consensus sits at a "Buy" with an average target near $245.
IBM's trajectory is tightly linked to enterprise IT budgets and the broader adoption of AI and hybrid-cloud infrastructure. As organizations redirect spending toward servers, storage, and graphics processing units (GPUs, the specialized chips powering AI workloads), IBM benefits through data, automation, and infrastructure software but can face near-term displacement in transactional licensing.
Interest rates and inflation shape corporate capital allocation: higher financing costs can delay large technology deployments, while sustained enterprise modernization and AI investment provide a structural tailwind. Currency movements, particularly a strengthening U.S. dollar, add another layer of sensitivity given IBM's global revenue base. Finally, the regulatory climate around AI, data governance, and semiconductors — including CHIPS Act funding — could either accelerate or constrain IBM's hardware and quantum roadmap.
Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may trend bullish, bearish, or sideways over the next week or month. Designed to surface developing trends, it can help users identify possible breakouts or reversals and explore predictions across a wide range of tradable instruments. The platform includes searchable prediction categories, historical context, and alert-oriented functionality to support timely monitoring. For investors tracking IBM's evolving setup, pairing fundamental analysis with AI-driven trend signals can add a valuable technical dimension to the decision-making process.
Looking across the remainder of 2026 and into 2027, IBM's case rests on whether its recurring software base can re-accelerate and absorb the volatility of its infrastructure cycle. Management expects software to approach double-digit growth in the second half, while free cash flow is still guided to increase by about $1 billion for the year — supporting a dividend that was raised for a 31st consecutive year.
Longer-term themes include the expansion of the hybrid-cloud and data-streaming franchises, the monetization of a generative AI book of business exceeding $12.5 billion, and margin sustainability driven by productivity and AI-enabled efficiency. IBM's quantum roadmap, which targets a large-scale fault-tolerant quantum computer around 2029, represents a high-upside but long-dated option. Offsetting these drivers are competitive pressure from hyperscalers, elevated leverage after acquisition spending, and the risk that enterprise deal timing remains uneven. Consensus expectations — a "Buy" rating with an average price target near $245 — suggest analysts see modest upside but remain watchful of execution.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of various computer products through the use of advanced information technology
Industry InformationTechnologyServices
A.I.dvisor indicates that over the last year, IBM has been loosely correlated with DXC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IBM jumps, then DXC could also see price increases.
| Ticker / NAME | Correlation To IBM | 1D Price Change % | ||
|---|---|---|---|---|
| IBM | 100% | -0.48% | ||
| DXC - IBM | 50% Loosely correlated | +5.05% | ||
| GIB - IBM | 49% Loosely correlated | +1.24% | ||
| ACN - IBM | 46% Loosely correlated | -1.94% | ||
| HCKT - IBM | 46% Loosely correlated | +0.37% | ||
| INFY - IBM | 45% Loosely correlated | -2.54% | ||
More | ||||
| Ticker / NAME | Correlation To IBM | 1D Price Change % |
|---|---|---|
| IBM | 100% | -0.48% |
| Technology Services category (400 stocks) | 14% Poorly correlated | +0.30% |
IBM saw its Momentum Indicator move below the 0 level on September 18, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 78 similar instances where the indicator turned negative. In 48 of the 78 cases, the stock moved further down in the following days. The odds of a decline are at 62%.
The Moving Average Convergence Divergence Histogram (MACD) for IBM turned negative on September 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 22 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 59%.
IBM moved below its 50-day moving average on September 24, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for IBM crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 57%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IBM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 55%.
IBM broke above its upper Bollinger Band on September 11, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.44% 3-day Advance, the price is estimated to grow further. Considering data from situations where IBM advanced for three days, in 248 of 377 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 167 of 264 cases where IBM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 63%.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.035) is normal, around the industry mean (7.462). P/E Ratio (19.598) is within average values for comparable stocks, (67.645). Projected Growth (PEG Ratio) (2.087) is also within normal values, averaging (2.284). IBM has a moderately high Dividend Yield (0.031) as compared to the industry average of (0.010). P/S Ratio (3.271) is also within normal values, averaging (141.758).
The Tickeron SMR rating for this company is 29 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. IBM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 94 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.